C. Laporte

Safety Margins for the Delineation of the Left Anterior Descending Artery in patients treated for breast cancer.

Y. Kirova, Eliot Nicolas, Nadjoua Khalifa, 2020, International journal of radiation oncology, biology, physics.

Crossing the perspectives of patients, families, and physicians on cancer treatment: A qualitative study

L. Verneuil, J. Sibeoni, G. Bousquet, 2016, Oncotarget.

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

C. Tournigand, M. Espié, B. Weber, 2019, The Lancet.